Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan

Int J Hematol. 2021 Mar;113(3):461-463. doi: 10.1007/s12185-020-03073-8. Epub 2021 Feb 9.

¹ Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
² Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. [email protected].
³ Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
⁴ Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
⁵ Department of Pediatrics, Osaka Red Cross Hospital, Osaka, Japan.
⁶ Department of Pediatrics, Fujita Health University, Toyoake, Japan.
⁷ Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan.

No abstract available

Keywords: 2-chlorodeoxyadenosine; Langerhans cell histiocytosis; Refractory/relapse.

Publication types